Legal Representation
Attorney
Teresa M. Hechmer
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 14, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 14, 2008 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 6, 2007 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 6, 2007 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 6, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 16, 2007 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 16, 2007 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 16, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 7, 2006 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 7, 2006 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 7, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 31, 2006 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 31, 2006 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 31, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 6, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 6, 2005 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 6, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 8, 2005 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 14, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 24, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Oct 5, 2004 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Sep 29, 2004 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 6, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 23, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 10, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005